Isaac Kohane: AI can be the Great Leveller for cancer care

Douglas Flora shared a post by Isaac Kohane on LinkedIn adding:

“If interested in AI in Breast Cancer, you would be hard-pressed to identify a better lineup, including AI in Precision Oncology editor Connie Lehman, John Halamka, and the ‘Simone Biles of Cancer AI’, my friend, Debra Patt. Brilliant people and agenda.

I’m not able to attend, and will be sad to miss their insights.

Maybe we can publish a summary of the event in the journal?

Someone take notes for me.

Sharing for reach.”

Quoting Isaac Kohane’s post:

“AI can be the Great Leveller for cancer care.

That’ll be my 15 minute thesis on September 20th.”

Additional information.
Source: Douglas Flora/LinkedIn and Isaac Kohane/LinkedIn

Douglas Flora is the Executive Medical Director of Oncology Services at St. Elizabeth Healthcare, overseeing clinical operations, strategic planning, and the expansion of cancer programs. He is also the co-founder of the Center for Precision Medicine; Genomic Health.

As the Editor-in-Chief of ‘AI in Precision Oncology,’ the first peer-reviewed academic journal dedicated to this field, he plays a pivotal role in advancing research. He is also an active board member of the American Cancer Society and ACCC, where he contributes to advocacy, education, and innovation within the cancer community.

Isaac Kohane is the Professor and Chair of Department of Biomedical Informatics and Professor of Pediatrics and Health Sciences and Technology at Harvard Medical School. He is a board member at Canary Medical Incorporated. He is the board director at Inovalon.